Fagron launches DiluCap, a line of excipients designed to help make capsule formulation easier and faster for compounding pharmacies. This line consists of six excipients and has been developed to help the performance of all types of APIs for oral use on solid dosage forms. The excipients were developed to avoid segregation between the API and the other formulation components, preserve API stability, and modulate the solubility and bioavailability of the API. Other benefits of this line include the elimination of the need for other adjuvants, a reduction of process time and the number of items in stock, and batch-to-batch reproducibility.